Hand holding the newspaper resting on a table with a cup of coffee


The Latest News From the Ivy Center

The Ivy Brain Tumor Center at Barrow Neurological Institute strives to be a valuable resource for any brain tumor or brain cancer-related media needs. Our media relations team is happy to help answer questions and arrange interviews. The expert neurosurgeons, neuro-oncologists and scientists at the Ivy Center are available to speak on a variety of topics. 

Our state-of-the-art media studio is available for audio and video interviews. We can also arrange filming opportunities at various locations around the center and labs. 

To contact the media relation team, call Jennifer Keeler at 602-670-4400 or email: [email protected]

Please see below for the latest media coverage and news from the Ivy Center. To read about our inspiring patients and those behind the scenes at the Ivy Center, visit the Ivy Blog. 

Taxonomy Icon
Glioblastoma Awareness Day Campaign Raises More Than $530K
  • July 26, 2019
Barrow Neurological Foundation led a fundraising effort that raised more than $539,000 for brain cancer research at the Ivy Brain Tumor Center on the first ever Glioblastoma Awareness Day, July 17, 2019.
Taxonomy Icon
Clinical Trial Identifies New Breast Cancer Drug As A Potential Therapy For Glioblastoma
  • July 25, 2019
The Ivy Brain Tumor Center at the Barrow Neurological Institute has released the results of its recent Phase 0 clinical trial of the breast cancer drug ribociclib (Kisqali®) for the treatment of recurrent glioblastoma.
Taxonomy Icon
By Targeting Each Patient’s Unique Tumor, Precision Medicine Is Crushing Once-Untreatable Cancers.
  • July 16, 2019
  • Source: Newsweek
Newsweek's cover story examines the rising success of precision medicine to fight once-untreatable tumors and highlights our efforts in using this method to fight glioblastoma where speed and personalization are key.
Taxonomy Icon
Could Karyopharm’s Newly Approved Multiple Myeloma Drug Also Work In Glioblastoma?
  • July 15, 2019
  • Source: FierceBiotech
The Ivy Brain Tumor’s goal is to try to speed advances into the clinic by testing potential therapies on tumor samples taken from patients who are currently battling glioblastoma—an approach its researchers hope will shed some light on the potential of Karyopharm’s new drug in treating the disease.
Taxonomy Icon
Ivy Brain Tumor Center And Karyopharm Therapeutics Collaborate To Develop Tissue-Based Clinical Trial For Brain Cancer
  • July 11, 2019
The Ivy Brain Tumor Center at the Barrow Neurological Institute has announced a partnership with Karyopharm Therapeutics (Nasdaq:KPTI) to accelerate the treatment of brain cancer.
Taxonomy Icon
The Ivy Brain Tumor Center Takes A ‘High Risk, High Reward’ Approach To Brain Cancer Trials
  • May 14, 2019
  • Source: MedCity News
"Our philosophy is that it is as important to fail fast as it is to succeed quickly," said Nader Sanai, the director of the Ivy Brain Tumor Center at Barrow Neurological Institute.
Taxonomy Icon
Ivy Brain Tumor Center fights to end deadly brain cancer
  • April 26, 2019
  • Source: Chamber Business News
In the heart of Phoenix, a team of doctors is vigilantly working to find a cure for Glioblastoma (GBM), the deadliest form of brain cancer.
Taxonomy Icon
Fighting Brain Cancer with Phase 0 Clinical Trials: An American Hero at Barrow Neurological Institute
  • April 14, 2019
  • Source: TrialSiteNews
The Ben & Catherine Ivy Foundation has provided a $50 million grant to Ivy Brain Tumor Center —these funds are powering the Phase 0 research in an attempt to combat brain cancer.
Taxonomy Icon
Phase 0 trials ‘quickest route’ for development of glioblastoma treatments
  • April 10, 2019
  • Source: Healio | HemOnc Today
Ivy Brain Tumor Center at The Barrow Neurological Institute has launched a program that offers phase 0 trials to accelerate the drug approval process for patients with glioblastoma.
Taxonomy Icon
A Bold Approach to Identify New and Effective Therapies for Malignant Brain Tumors
  • April 8, 2019
  • Source: The Onco'Zine Brief
In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Nader Sanai an internationally-recognized neurosurgical oncologist with clinical and research expertise in the treatment of all brain tumors, including glioblastoma, the most aggressive cancer that begins within the brain.